"We are happy to welcome Wellington Partners to our high-profile investor base. I am sure our company will gain significantly from the experience and network of Erich Schlick and Wellington Partners."
Dr. Jacques Souquet
CEO, SuperSonic Imagine
Wellington contact:
Erich Schlick
| Advancing the art of ultrasound imaging |
French medtech company SuperSonic Imagine (SSI) focuses on diagnostic ultrasound systems. The company is leveraging a breakthrough technology, developed at the Laboratoire Ondes et Accoustique CNRS, Paris, and holds the exclusive worldwide rights to key patents in the field of elastography. Based on this technology , SSI is building a unique ultrasound imaging system, combining conventional 2D imaging and Doppler with an ultra fast acquisition mode (>5000 frames/sec) for elastographic imaging – a new method to visualize the elastic properties of soft tissues and thereby detect malignant tumors even at early stages. At first, the company is focusing on breast cancer, which has the No. 1 incidence among all women’s cancers, but in time the same device will subsequently be adapted, via software and different probes, for use in other major organ systems.
SSI launched its first product in Q4/2008 in the EU. After closing the Series B round with the participation of Wellington Partners, the company will now roll out this product in all major markets and develop further applications of its unique technology.
First investment: April 2009
Supersonic Imagine
Les jardins de la Duranne
510 Rue René Descartes
13857 Aix-en-Provence
France
